| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/20/2004 | US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune |
| 05/20/2004 | US20040096451 Preventing, treating or ameliorating symptoms associated with respiratory syncytial virus (RSV), parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection, the methods comprising administering to a subject an effective amount of |
| 05/20/2004 | US20040096444 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096436 Method for treating cancer comprising administering to a subject in need of such treatment a therapeutically effective amount of a member selected from an inhibitor of a protein kinase, an enantiomer of such a compound, a prodrug of such a |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/19/2004 | EP1419784A2 Proteosome vaccines against toxins, allergy and cancer |
| 05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419244A2 Electrodes coated with treating agent and uses thereof |
| 05/19/2004 | EP1419240A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
| 05/19/2004 | EP1419179A2 Antigen binding domains from fish |
| 05/19/2004 | EP1419175A2 Replikin peptides and uses thereof |
| 05/19/2004 | EP1418948A1 Replicating adenovirus vectors |
| 05/19/2004 | EP1418942A2 Poxvirus-containing compositions and process for their preparation |
| 05/19/2004 | EP1418941A2 Vaccination against the feline immunodeficiency virus |
| 05/19/2004 | EP1418940A2 Dna expression vectors and methods of use |
| 05/19/2004 | EP1418939A2 Calcium phosphate particles as mucosal adjuvants |
| 05/19/2004 | EP1418938A1 Bont/e or snap-25e for treating botulinum toxin a or c1 poisoning and inhibiting muscle contraction |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1229936B1 Use of anti-idiotypical antibodies as vaccines against cancer |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | EP0832253B1 Nucleic acid respiratory syncytial virus vaccines |
| 05/19/2004 | EP0801572B1 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 05/19/2004 | EP0787190B1 Hepatitis e virus antigens and uses therefor |
| 05/19/2004 | EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1150331C A group of efficient expression carriers for humanized antibody of mummal cell |
| 05/19/2004 | CN1150328C Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B |
| 05/19/2004 | CN1150318C Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/19/2004 | CN1150314C Immunity enhancing lactic acid bacteria |
| 05/19/2004 | CN1150033C Immunopptentiating composition |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/18/2004 | US6737523 For treatment of various forms of cancer |
| 05/18/2004 | US6737522 Chicken interleukin-15 and uses thereof |
| 05/18/2004 | US6737521 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 05/18/2004 | US6737514 Compositions and methods for the therapy and diagnosis of lung cancer |
| 05/18/2004 | US6737513 Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same |
| 05/18/2004 | US6737511 With two domains that target cell and modify apoptotic response |
| 05/18/2004 | US6737406 Cryptic peptides and method for their identification |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737248 Apparatus for use in the detection of bacterial infections |
| 05/18/2004 | US6737237 Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737067 Composition comprising purified recombinant trimer of hiv gp160 which binds to cd4, binds to anti-gp120 antibody capable of neutralizing hiv infection of cells in vitro, binds to anti-gp41 antibody, and has no inter-chain disulfide bridges |
| 05/18/2004 | US6737066 HIV immunogenic compositions and methods |
| 05/18/2004 | US6737063 Immunological polypeptides; vaccine against gramnegative bacteria |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737055 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/13/2004 | WO2004040262A2 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/13/2004 | WO2004039967A1 Immortalized natural killer cell line |
| 05/13/2004 | WO2004039950A2 Activation of hcv-specific cells |
| 05/13/2004 | WO2004039945A2 Preventive and therapeutic aids vaccines |
| 05/13/2004 | WO2004039417A2 Drying process |
| 05/13/2004 | WO2004039413A1 Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides |
| 05/13/2004 | WO2004039400A2 Bhv5 mutants |
| 05/13/2004 | WO2004039399A1 Immunogenic composition |
| 05/13/2004 | WO2004039398A1 Hm1.24-utilizing cancer vaccines |
| 05/13/2004 | WO2004039337A2 Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization |
| 05/13/2004 | WO2004039329A2 Treatment of immunological renal disorders by lymphotoxin pathway inhibitors |
| 05/13/2004 | WO2004039244A2 Methods and kits for diagnosing tumorigenicity |
| 05/13/2004 | WO2004039234A2 Humanized antibodies against the venezuelan equine encephalitis virus |
| 05/13/2004 | WO2004020609A9 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003068163A3 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003049762A3 Immunisation against chlamydia trachomatis |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003005636A8 Secure header information for multi-content e-mail |
| 05/13/2004 | WO2002089731A9 Agents for treatment of hcv and methods of use |
| 05/13/2004 | WO2002085447A8 Microprojection array having a beneficial agent containing coating |
| 05/13/2004 | WO2002047703A8 Immune system stimulation |
| 05/13/2004 | WO2002016440A9 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | US20040092911 Ophthalmic drug delivery device |
| 05/13/2004 | US20040092907 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092719 Using hydrophobic interaction chromatography to separate and isolated heavy chain modified immunoglobulins |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092472 Nucleic acid compositions for stimulating immune responses |
| 05/13/2004 | US20040092468 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 05/13/2004 | US20040092446 HA-1 epitopes and uses thereof |
| 05/13/2004 | US20040092445 Increasing hematopoietic progenitor cells in a mammal by adminstering an interleukin-like polypeptide |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091995 Replication defective poxvirus coding granulocyte-monocyte-colony stimulating factor (GM-CSF) for treatment and prevention of neutropenia and tumor disorders; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091971 Preparing messenger RNA coding plasmodial apical membrane antigen for developing malarial vaccine |